chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The morning after patient was vaccinated he began acted very differently than his normal extremely happy. self. He almost never cries or fusses and people are astounded at the constant smile on his face. He loves to cuddle but also loves playing independently. First thing this morning pt was screaming a high pitched shriek and was stiff and arching his back when I was changing his diaper. He continued to shriek throughout the day. I have never ever heard this from him. He was very fussy and inconsolable throughout the entire day. He kept pushing away from me, yet wanted to be held and would not play independently at all.
Around 9:45 pm that night started to feel my throat swelling a little ,woke up to bad  burning rashes on both my arms,sweating ,fast heart beat rash got worse and my throat felt like it was swelling on and off jittery
On 02/20/2001 the patient developed a mild case of chicken pox that included lethargy, itch, 50 vesicles, red spots on her back, chest, face, legs and arms. The patient was exposed at school one week prior. The patient was treated with Benadryl for the itch. The patient sought medical attention. No further information is expected.
Rash diffuse, red papular, onset with 24 hrs of 6 month immunizations, subsequent fever to 103, fussiness, vomiting
I had congestion, stiff neck and lethargy following the shot. I assumed it was just seasonal allergies. It has been a couple of months and I still have daily congestion, some mild body aches, stuffy nose and ears and wonder if it might have something to do with the shot. I do not normally get seasonal allergies, These symptoms continue to persist into what is now late July. I just wanted to document my experience here to see if others have similar persistent symptoms.
t103 1 1/2hr p/vax;screaming x 5hr;t101 p/APAP;sl fussy next AM w/rash on stomach
pt recvd vax & pt almost fainted, was pale always responsive; recovered w/5-10mins
Dizziness; Mild headache; Loss of energy; Felt drained; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Loss of energy), FEELING ABNORMAL (Felt drained), DIZZINESS (Dizziness) and HEADACHE (Mild headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced ASTHENIA (Loss of energy), FEELING ABNORMAL (Felt drained) and HEADACHE (Mild headache). On 27-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, ASTHENIA (Loss of energy), FEELING ABNORMAL (Felt drained), DIZZINESS (Dizziness) and HEADACHE (Mild headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided. Treatment information was not provided.
Significant swelling/redness as far as 15cm from site of injection; limp; discomfort.
Information has been recieved form a pharmacist concerning a 5 year old female who was vaccinated with a dose of varicella virus vaccine live. The pharmacist reported that on  an unknown date, the pt developed chickenpox. It was noted that the breakthrough chicken pox improved and the pt was recovering. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
PATIENT AND FAMILY MEMBER INDICATE THAT SINCE FRIDAY IN THE EARLY MORNING, HE GAVE HIM CHILLS FEVER AND DID NOTE THAT HE HAD AN EASY PARALYSIS WHILE SLEEP. SATURDAY AND SUNDAY HE WAS WITHOUT GETTING UP FROM THE BED, HE DIDN'T GO TO THE DOCTOR UNTIL MONDAY MORNING. IT INDICATES THAT THE DAY THE VACCINE WAS ADMINISTERED HAD DIZZINESS AND HE FEELS BAD, BUT I DO NOT COMMENT ANYTHING TO ANYONE
This spontaneous report was received from a medical assistant regarding possibly 3 patients of unknown age and gender. The RECOMBIVAX HB vaccines were exposed to temperatures between 32F and 34F for 10 days on 02-MAY-2016, 09-MAY-2016, 10-MAY-2016, 13-MAY-2016, 17-MAY-2016, 19-MAY-2016, 20-MAY-2016, 24-MAY-2016, 25-MAY-2016 and 28-MAY-2016. There was no previous temperature excursion reported. On an unknown date approximately in 2016, the patients were vaccinated with improperly stored RECOMBIVAX HB (lot# L004754 expiry 10-NOV-2016 and L040458 expiry: 04-FEB-2018). No adverse effects were reported. This is 1 of 2 reports from the same reporter. Additional information has been requested.
Irregular period between periods for 2 cycles, increased flow for 3 and increased pain that has been getting better each cycle but hasn?t quite gone back to pre-vaccine pain level yet.
Swelling and pain of knees. Ankles. Fingers. Toes.  SOB.  Extreme fatigue.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adolescent male patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to BEXERO. Additional details were provided as follows: the age at vaccination was not reported. the patient experienced a little pain at the injection site after his 1st dose of BEXSERO. the reporter did not want to provide her complete demographics or answer any questions for this report.
SORE ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
LEFT EYE SORENESS ON THE OUTER PART AROUND THE EYE AND SPREADING TO THE INSIDE; LEFT EYE SWELLING ON THE OUTER PART AROUND THE EYE AND SPREADING TO THE INSIDE; ACHES; CHILLS; FEVER; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 54 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAY-2021, the subject experienced aches. On 07-MAY-2021, the subject experienced chills. On 07-MAY-2021, the subject experienced fever. On 07-MAY-2021, the subject experienced nausea. On 07-MAY-2021, the subject experienced fatigue. On 08-MAY-2021, the subject experienced left eye soreness on the outer part around the eye and spreading to the inside. On 08-MAY-2021, the subject experienced left eye swelling on the outer part around the eye and spreading to the inside.  Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine  was not applicable. The patient recovered from aches, chills, fever, and nausea on 08-MAY-2021, was recovering from fatigue, and had not recovered from left eye soreness on the outer part around the eye and spreading to the inside, and left eye swelling on the outer part around the eye" and spreading to the inside. This report was non-serious.
pt recvd vax 24-48 hrs later,exp diarrhea,nausea,abd pain,fever,h/a,& aches in upper rt chest;these sx lasted 3 days & resolved;
It started with small bumps on my right arm, itching bumps, the bumps just kept increasing all over my right arm, then left and some got to my back. Those bumps were really itchy and got some redness and left marks were they were
On July 6, 2021 I went to hospital for an ECG because I was going to have a myomectomy surgical procedure scheduled for 7/12/21.  The results for my ECG came back abnormal and showed that I had  Left Bundle Branch Block (LBBB). Since the ECG came back abnormal, I was referred to specialist. I had an appointment with specialist on 7/22/21 and an Echocardiogram that same day.  The results for the ECG was abnormal and showed that I had LBBB. Specialist then scheduled me to have a stress test on 7/28/21 and 7/29/21 which showed  LBBB with heart failure with reduced ejection fracture.
Patient was given a FLUMIST at the County Health Dept on 9-24-12. While with his father & stepmother, he received a flu vaccine injection on 9-28-12.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 63-year-old male patient received BNT162b2 (BNT162B2), on 28Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: patient received other medication in 2weeks. product: COVID 19 Treatment, brand: Paxlovid treatment start date: Jul2022, treatment stop date: Jul2022 for Treatment of COVID-19, adverse event start date: 13Jul2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Drug ineffective and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
This spontaneous report as received from a nurse refers to one of three patients of unknown age. On an unspecified date the patients was vaccinated with a dose of PNEUMOVAX23 (Lot#, dose and route not reported, but the three patients got the vaccine from the same lot number). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patients experienced a greater tenderness, which was tender to the point of being painful. The patients sought for unspecified medical attention. This is one of several reports received from a same source. Additional information has been requested.
After pt received his 1st HPV pt became diaphoretic, pale, vomited and fainted per father and nurse. Pt also complained of ringing in both ears. Vital Signs obtain and provider in to check patient. Pt instructed to lay down, pt left after about 20 minutes. Per nurse that gave vaccine pt was walking fine without difficulty. Father discharge with instructions.
Patient states she had a temp. of 103.4, Body aches, and swollen oral mucosa.
Painful enlarged lymph node in ipsilateral axilla to site of injection.  Lymphadenopathy persisted w/ painful enlargement x 9 months and continued pain currently, 1 year later a
A non-serious spontaneous report of administration of expired product was received from a health professional concerning an eight-year-old female. Neither medical history nor concomitant medication was reported for this patient. The product expired on 15-Dec-2010. On 30-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 10-Mar-2011 and incorporated into case: no late occurring adverse events.
Fever,  chills, body aches. Swelling at site for 2+ days. Lymph node swelling
severe ringing to ears for four days; throat was a bit congested; difficulty of swallowing; something stuck in the throat; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date: unknown), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to ask if it is normal to have severe ringing to ears especially in the morning. The patient received the COVID 19 vaccine last 16Jan2021. The patient reported symptoms which she has been experiencing for 4 days now with the COVID 19 vaccine, Pfizer's. She experienced severe ringing to ears for four days since 16Jan2021, it has been happening for four days, and usually happens in the morning and also, in Jan2021, there was something stuck in the throat, like her throat was a bit congested with difficulty of swallowing. The throat was being ok now, it's getting better, but the severe ringing to her ears was her main concern. The patient was recovering from the events "something stuck in the throat", "throat was a bit congested" and "difficulty of swallowing" while the event "severe ringing to ears for four days" had not resolved.   Information on the lot/batch number has been requested.
Pt presented with chest pain worse with inspiration, fuond to have positive cardiac markers. Evaluated and thought likely myopericarditis.
Information has been received from a pharmacist referring a 60 years old male patient. The patient's concurrent conditions, medical history and concomitant medication were not reported. The patient had no drug allergies. On 17-SEP-2016, the patient was vaccinated with ZOSTAVAX (dose and route were unknown, lot# L044530, expiration date 09-FEB-2017. On the same date after receiving the ZOSTAVAX, the patient experienced redness around the injection site. The patient did not seek medical attention and no treatment was given for the event. No lab diagnostics studies were performed. The patient did not recover from the event. The reporter considered the event to be related to ZOSTAVAX. This is one of two reports received from the same reporter. Additional information has been requested.
I experienced pain in my left arm and when I bend down or breathe in hard it hurts.
Case number PHEH2014US024953, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 49-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 22 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Light headed and some blurred vision 20 minutes after shot that lasted just a few minutes then some tingling in left leg and then started to notice hives on my hands and body, also had welts on my stomach after arriving at home. all of these events took place within the first hour. now several days later I still have the hives and non stop itching even in places that I dont have hives. my over all skin on my body just feels itchy
Patient received Pfizer COVID vaccine on 1/29/21 and 2/20/21. On 2/2/22, patient had v. fib arrest at  home (intubated in the field) and admitted to our CCU with acute hypoxic respiratory failure, acute encephalopathy, cardiogenic shock, and GI bleed. Patient was also tested positive for COVID during admission. As of today (2/4/22), patient is still admitted in CCU intubated.
Area very swollen, red, itchy, painful for 5 days after. Unable to sleep on arm for 5 days. HDC cream applied often, but site still itchy and very painful.
Three days ago had bumps on face, spreading today to abdomen, neck and back. To use Benadryl and Calamine lotion
At 10:00, pt reported feeling lightheaded. VS 98%, 96/42, 53. At 10:06, 82/49, 64. At 10:09, pt assisted to recliner chair and reclined, reports dizziness subsiding. At 10:15, 122/84, 77, 99%. Pt dc'd without dizziness completely resolved.
some soreness; some stiffness; I am concerned that I received the 2nd dose from a facility that had a power outage; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (some soreness), MUSCULOSKELETAL STIFFNESS (some stiffness) and PRODUCT TEMPERATURE EXCURSION ISSUE (I am concerned that I received the 2nd dose from a facility that had a power outage) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PAIN (some soreness), MUSCULOSKELETAL STIFFNESS (some stiffness) and PRODUCT TEMPERATURE EXCURSION ISSUE (I am concerned that I received the 2nd dose from a facility that had a power outage). At the time of the report, VACCINATION SITE PAIN (some soreness), MUSCULOSKELETAL STIFFNESS (some stiffness) and PRODUCT TEMPERATURE EXCURSION ISSUE (I am concerned that I received the 2nd dose from a facility that had a power outage) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
As soon as I landed at the airport I was vaccinated with the PFIZER Vaccine. Immediately after the vaccine the sense of taste and smell have been affected me. I don't sense the same smells and flavors.
I had a headache, around 7pm got a mild fever 99.8 with chills.
No desire to eat or drink; Joint ache; Exhausted; Nausesous; Lightheaded; I was hot; Face was flush looking; Tip of her tongue was feeling numb, Lips were feeling numb; Mouth kept salivating; Temperature 92.5F; Felt clammy; A report was received from a [consumer/physician/nurse/pharmacist/healthcare facility staff member] concerning a 61 year- old patient who was participating in the mRNA-1273 Emergency Use Program and developed lightheadedness, felt hot, felt clammy, face was flush, tip of her tongue and lips were numb, exhaustion, nausea, salivating, decreased body temperature, joint ache, and no appetite or thirst.  The patient's medical history, as provided by the reporter, included autoimmune disorder. No relevant concomitant medications were reported.   On 05 Jan 2021, immediately prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection.   The patient began feeling lightheaded, hot, her face was flush looking, and the tip of her tongue and lips became numb.  Approximately three hours after receiving the vaccine she became nauseous, she was salivating, her temperature was 92.5° F, she felt clammy, and exhausted.  On 06 Jan 2021 her nausea continued, her temperature was 93° F, salivating continued, and her joints ached.  On 07 Jan 2021 her nausea continued and she had no desire to eat or drink. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided .   The outcome of the events lightheadedness, felt hot, face was flush, nausea, salivating, decreased body temperature, joint ache, and no appetite or thirst were not reported.  The outcome of the events tip of her tongue and lips were numb were recovered/resolved.  Reporter causality for the events was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Headache, fever, chills, migraine, nausea, vomiting, stomach cramps, muscle ache, muscle spasms... got vaccine at 10:00 am-symptoms appeared around 6:00 pm with tiredness/uncomfortableness/achyness... ramped around over the next few hours, becoming severe around 10:00 pm. At about 11:00 pm, Ambulance was dispatched and patient was brought to ER at 11:30 pm under the care of doctor. Patient received 1000 mL IV fluid plus Zofran, Reglan, IV Tylenol and Toradol over the course of 4-5 hours. Patient was then released around 5:00 am on the morning of 3/22. Patient felt much better and was stable and improved.
Fever to 104.3R, 15min of rhythmic jerking followed by sleepiness/weak cry; Admitted for evaluation of poss sz;
4:07 pm Vaccinating nurse said client was unresponsive to verbal stimuli, breathing even and unlabored.  4:08 pm client alert and orientated. According to patient, "I usually faint when I receive any vaccine of by blood pressure taken."  4:10 pm Client evaluated by onsite Paramedics.  4:12 pm client able to ambulate without any difficulties.  4:15 pm client expressed a phobia of needles.  4:40 pm client placed on 30 mins. of additional observation.  4:55 pm no additional symptoms observed and paramedics released to go home.  5:00 pm client released.
FEVER; INTENSE BODY ACHES; FEELING OF WARMTH; DIZZINESS; STIFF NECK; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic, and non smoker, and other pre-existing medical conditions included patient had no known drug allergy and drug abuse or illicit drug.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A ) dose was not reported, administered on 11-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced dizziness. On 11-APR-2021, the subject experienced stiff neck. On 11-APR-2021 16:20, the subject experienced feeling of warmth. On 11-APR-2021 23:00, the subject experienced intense body aches. On 12-APR-2021 04:30, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling of warmth, dizziness, intense body aches, fever, and stiff neck. This report was non-serious.
New embolic strokes requiring hospitalization and mechanical ventilation due to mental status.  New lower and upper DVT, unable to anticoagulated due to new strokes. Symptoms started acutely on day of admission, 4 days after vaccination
This spontaneous report was received from a 77 year old female patient regarding herself. Patient's current condition included asthma. No drug reactions were reported. On 16-SEP-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot# expiry not reported). On an unknown date in approximately September 2013, the patient was vaccinated with a dose of Influenza virus vaccine (manufacturer unknown). Concomitant therapies included fluticasone propionate, Advair and Singulair. On 17-SEP-2013, the patient experienced flu like symptoms. Patient received treatment with unspecified over the counter decongestant. No laboratory tests were performed. No medical attention was sought. The outcome of flu like symptoms was reported as not recovered. Additional information is not expected.